The influence of hyper- and hypoglycemia on glucose uptake into human circulating lymphocytes. An in vitro study

Diabetologia Doswiadczalna i Kliniczna

Volumn 7, Issue 3, 2007, Pages 131-138

  Szablewski, Leszek ^a   Raszka, Karina ^a   Oleszczak, Bozenna ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

Deoxy D glucose; Glucose; Glucose transporters; Lymphocytes

Indexed keywords

DEOXYGLUCOSE; GLUCOSE TRANSPORTER 1; GLUCOSE TRANSPORTER 3; GLUCOSE TRANSPORTER 4;

ADULT; ARTICLE; BLOOD SAMPLING; CELL ISOLATION; DENSITY GRADIENT CENTRIFUGATION; FEMALE; GLUCOSE TRANSPORT; HUMAN; HUMAN CELL; HYPERGLYCEMIA; HYPOGLYCEMIA; LYMPHOCYTE; MALE; PROTEIN EXPRESSION;

EID: 34548853155     PISSN: 16433165     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Wagman AS, Nuss JM. Current therapies and emerging targets for the treatment of diabetes. Curry Pharm Design 2001; 7: 417-450.
2. Wood IS, Trayhurn P. Glucose transporters (GLUT and SGLT): expanded families of sugar transport proteins. Br J Nutr 2003; 89: 43-49.
3. Desjeux J-F. The molecular and genetic base of congenital transport defects. Gut 2000; 46: 585-587.
4. +/glucose cotransporter 1 (SGLT1) J Cell Biochem 2003; 90: 339-346.
5. +-to-sugar stoichio-metry of SGLT3. Am J Physiol - Ren Fluid & Electrol Physiol 2001; 280: F278-F282.
6. Diez-Sampedro A, Hirayama BA, Osswald C. et al. A glucose sensor hinding in a family of transporters. Proc Natl Acad Sci USA. 2003; 100: 11753-11758.
7. Joost HG, Mueckler M, Bell GI. et al. Nomenclature of GLUT/ /SLC2A family of sugar/polyol transport facilitators. Am J Physiol 2002; 282: E 974-1076.
8. Joost HG, Thorens B. The extended GLUT - family of sugar/polyol transport facilitators - nomenclature, sequence characteristics and potential function of its novel members. Mol Membr Biol 2001; 18: 247-256.
9. Longo M, Elsas LJ. Human glucose transporters. Adv Pediatr 1998; 45: 293-313.
10. Jung CY, Lee W. Glucose transporters and insulin action: some insights into diabetes management. Arch Pharm Res 1999; 22: 329-334.
11. Fu Y, Maianu L, Melbert BR, Garvey WT. Facilitative glucose transporter gene expression in human lmphocytes, monocytes, and macrophages: a role of GLUT isoforms 1, 3, and 5 in the immune response and foam cell formation. Blood Cells Mol Dis 2004; 32: 182-190.
12. Joshi N, Caputo GM, Weitekamp MR, Karchmer AW. Primary care: infection in patients with diabetes mellitus. N Engl J Med 1999; 34: 1906-1912.
13. Otton R, Mendonca JR, Curie R. Diabetes causes marked changes in lymphocyte metabolism. J Endocrinol 2002; 174: 55-61.
14. Szablewski L, Pia̧tkiewicz P, Oleszczak B, Nowak Ł, Sobczyk A, Grytner-Ziȩcina B. Wpływ leczenia insulina̧ chorych na cukrzycȩ typu 2 na pobieranie deoksy-D-glukozy przez limfocyty krwi obwodowej. Diab Dośw i Klin 2004; 4: 217-223.
15. Pia̧tkiewicz P, Czech A, Tatoń J. i wsp. Glucose transport into lymphocytes in healthy subjects and in patients with type 2 diabetes mellitus. Medycyna Metabol 2003; 7: 12-17.
16. Pia̧tkiewicz P, Tatoń J, Czech A, Szablewski L. Farmakologiczna modyfikacja transportu glukozy do limfocytów osób chorych na cukrzycȩ typu 2. Diabetol Pol 2003; 10: 88.
17. Pia̧tkiewicz P, Szablewski L, Czech A, Tatoń J, Oleszczak B, Kasprzycka M. Badania transportu glukozy do limfocytów osób zdrowych i chorych na cukrzycȩ typu 2. Medycyna Metanol 2002; 6: 15-21.
18. Szablewski L. Zaburzenia dokomórkowego transportu deoksy-D-glukozy do wybranych krwinek krwi obwodowej u osób chorych na cukrzycȩ typu 2. Wpływ choroby i sposobu leczenia na transporter glukozy w tych komórkach. Oficyna Wydawnicza AM w Warszawie. 2006: 1-100.
19. Pia̧tkiewicz P, Szablewski L, Czech A, Tatoń J, Oleszczak B, Sobczyk A. Badanie ekspresji genów GLUT w limfocytach osób zdrowych i chorych na cukrzycȩ typu 2. Diabetol Pol 2003; 10: 41.
20. Mostert M, Rabbone I, Piccinini M. i wsp. Derangements of pyruvate dehydrogenase in circulating lymphocytes of NIDDM patients and their healthy offspring. J Endocrinol Invest 1999; 22: 519-526.
21. Rinaudo MT, Curto M, Rabbone I, Piccinini S, Gamba S. Effect of sulfonylurea agents on pyruvate dehydrogenase activity in circulating lymphocytes from patients with non-insulin-dependent diabetes mellitus (NIDDM). J Diabet Compl 1994; 8: 221-225.
22. Elhadd T, Bancroft A, McLaren M, Newton RW, Belch JJF. Increased granulocyte aggregation in vitro in diabetes mellitus. QJM 1997; 90: 461-464.
23. Kaneshige H, Endoh M, Tomino Y, Nomoto Y, Sakai H, Arimori S. Impaired granulocyte function in patients with diabetes mellitus. Tokaj J Exp Clin Med 1982; 7: 77-80.
24. Moriguchi S, Kato M, Sakai K, Yamamoto S, Shimizu E. Decreased mitogen response of splenic lymphocytes in obese Zucker rats is associated with the decreased expression of glucose transporter 1 (GLUT-1). Am J Clin Nutr 1998; 67: 1124-1129.
25. Korgun ET, Demir R, Sedlmayr P. et al. Sustained hypoglycemia affects glucose transporter expression of human blood leukocytes. Blood Cells Mol Dis 2002; 28: 152-159.
26. Kaliman P, Vin̄als F, Testar X, Palacin M, Zorzano A. Disruption of Glut 1 glucose carrier traficking in L6E9 and Sol 8 myoblasts by the phosphatidylinositol 3-kinase inhibitor wortmanin. Biochem J 1995; 312: 471-477.
27. Szablewski L, Oleszczak B, Malejczyk J, Osiecka A, Hyc A, Borsuk P. Facilitative glucose transporters in rat chondrocytes. Eur. J. Cell Biol. 2000; Suppl: 113-115.
28. 2+-dependent mechanism. J Amer Diabetes Association 1995; 44: 1345-1348.
29. Lewko B, Bryl E, Witkowski JM, Latawiec E, Angielski S, Stȩpiński J. Mechanical stress and glucose concentration modulate glucose transport in cultured rat podocytes. Nephrol Dial Transplant 2005; 20: 306-311.
30. De Vos A, Heimberg H, Quartier E, Huypens L, Pipeleers D, Schuit F. Human and rat β-cells differ in glucose transporter but not in glucokinase gene expression. J Clin Invest 1995; 96: 2489-2495.
31. Ahn Y, Kim J, Lee B, Kim Y. Cloning and characterization of rat pancreatic β-cell liver type glucose transporter gene; a unique exon/intron organization. Arch Biochem Biophys 1995; 323: 387-396.
32. Doege H, Bocianski A, Joost HG, Schurmann A. Activity and genomic organization of human glucose transporter 9 (GLUT 9), a novel member of the family of sugar-transport facilitators predominantly expressed in brain and leucocytes. Biochem J 2000; 350: 771-776.
33. Estrada DE, Elliott E, Zinman B. et al. Regulation of glucose transport and expression of GLUT 3 transporters in human circulating mono-nuclear cells: studies in cells from insulin-dependent diabetic and nondiabetic individuals. Metab Clin Exp 1994; 43: 591-598.
34. Daneman D, Zinman B, Elliot ME, Bilan PJ, Clip A. Insulin-stimulated glucose transport in circulating mononuclear cells from nondiabetic and IDDM subject. Diabetes 1998; 37: 667-684.
35. Nout YS, Hinchcliff KW, Jose-Cunilleras E, Dearth LR, Sivko GS, DeWille JW. Effect of moderate exercise immediately followed by induced hyperglycemia on gene expression and content of the glucose transporter-4 protein in skeletal muscles of horses. Am J Vet Res 2003; 64: 1401-1408.
36. Hunter SJ, Garvey WT. Insulin action and insulin resistance: diseases involving defects in insulin receptors, signal transduction, and glucose transporter effector system. Am J Med 1998; 105: 331-345.
37. Kainulainen H, Järvinen T, Heinonen PK. Placental glucose transporters in fetal intra-uterine growth retardation and macrosomia. Gynecol Obstet Invest 1997; 44: 89-92.
38. Goodyear LJ, Hirshman MF, Napoli R. et al. Glucose ingestion causes GLUT 4 translocation in human skeletal muscle. Diabetes 1996; 45: 1051-1056.
39. Galante P, Mosthaf L, Kellerer M. i wsp. Acute hyperglycemia provides an insulin-independent inducer for GLUT 4 translocation in C2C12 myotubes and rat skeletal muscle. J Amer Diabetes Association 1995; 44: 646-651.
40. Mathoo JMR, Shi ZQ, Klip A, Vranic M. Opposite effects of acute hypoglycemia and acute hyperglycemia on glucose transport and glucose transporters in perfused rat skeletal muscle. J Amer Diabetes Association 1999; 48: 1281-1288.
41. Pliszka M, Szablewski L, Oleszczak B. Effects of IGF-1 on deoxy-D-glucose uptake by human peripheral blood lymphocytes. Diab Dośw i Klin 2006; 6: 314-319.
42. Uehara Y, Nipper V, McCall AL. Chronic insulin hypoglycemia induces GLUT3 glucose transporter protein in adult rat brain parenchyma. Diabetes 1996; 45: 164 A.
43. Smoak IW, Branch S. Glut-1 expression and its response to hypoglycemia in the embronic mouse heart. Anat Emrbyol (Berl) 2000; 201: 327-333.
44. Harik SI, Behmand RA, Arafah BM. Chronic hyperglycemia increases the density of glucose transporters in human erythrocyte membranes. J Clin Endocrinol 1991; 72: 814-818.
45. Xie WS, Yuc JC, Tu YP. Fluorescence study of ligand induced conformational changes of human erythrocyte glucose transporter. Biochem Mol Biol Int 1996; 39: 279-284.
46. Bagdade JD, Stewart M, Walters E. Impaired granulocyte adherence. A reversible defect in host defense in patients with poorly controlled diabetes. Diabetes 1978; 27: 677-681.